Showing results (321-330 of 438) with videos related to
Sort By:
Pageof 44
Circulation. Cardiovascular Interventions|January 14, 2021
Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial InfarctionBjörn Redfors, Reza Mohebi, Gennaro Giustino, et al.Clinical Cardiology|April 3, 2008
Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney diseaseChiara Melloni, Karen P Alexander, Sarah Milford-Beland, et al.The American Journal of Cardiology|July 31, 2003
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)Thaddeus R Tolleson, L Kristin Newby, Robert A Harrington, et al.American Heart Journal|June 20, 2006
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromesMatthew T Roe, Eric D Peterson, L Kristin Newby, et al.Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.Journal of Thrombosis and Thrombolysis|June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committeeE Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.Circulation. Cardiovascular Interventions|July 22, 2010
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialAlexandra J Lansky, Kenji Goto, Ecaterina Cristea, et al.Journal of the American College of Cardiology|November 22, 2008
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromesDuane S Pinto, Gregg W Stone, Chunxue Shi, et al.International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 7, 2019
Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathyJuan J Russo, Megha Prasad, Darshan Doshi, et al.Pageof 44